Dallemole, D.R.; Terroso, T.; Alves, A.d.C.S.; Scholl, J.N.; Onzi, G.R.; Cé, R.; Paese, K.; Battastini, A.M.O.; Guterres, S.S.; Figueiró, F.;
et al. Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane. Pharmaceutics 2021, 13, 862.
https://doi.org/10.3390/pharmaceutics13060862
AMA Style
Dallemole DR, Terroso T, Alves AdCS, Scholl JN, Onzi GR, Cé R, Paese K, Battastini AMO, Guterres SS, Figueiró F,
et al. Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane. Pharmaceutics. 2021; 13(6):862.
https://doi.org/10.3390/pharmaceutics13060862
Chicago/Turabian Style
Dallemole, Danieli Rosane, Thatiana Terroso, Aline de Cristo Soares Alves, Juliete Nathali Scholl, Giovana Ravizzoni Onzi, Rodrigo Cé, Karina Paese, Ana Maria Oliveira Battastini, Silvia Stanisçuaski Guterres, FabrÃcio Figueiró,
and et al. 2021. "Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane" Pharmaceutics 13, no. 6: 862.
https://doi.org/10.3390/pharmaceutics13060862
APA Style
Dallemole, D. R., Terroso, T., Alves, A. d. C. S., Scholl, J. N., Onzi, G. R., Cé, R., Paese, K., Battastini, A. M. O., Guterres, S. S., Figueiró, F., & Pohlmann, A. R.
(2021). Nanoformulation Shows Cytotoxicity against Glioblastoma Cell Lines and Antiangiogenic Activity in Chicken Chorioallantoic Membrane. Pharmaceutics, 13(6), 862.
https://doi.org/10.3390/pharmaceutics13060862
